MicroPort MedBot (2252.HK) Proposes New Directors, Amends Governance Documents, and Convenes EGM

Bulletin Express

11/06

Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK) has announced plans to appoint six new directors and amend its corporate governance documents. The new directors include four non-executive candidates—namely, Dr. Chang Zhaohua, Mr. Hiroshi Shirafuji, Mr. Norihiro Ashida, and Ms. Liang Min—as well as two independent non-executive candidates, Mr. Jonathan H. Chou and Dr. Guoen Liu. Upon approval, the Board will expand from eight to eleven members.

The company has also proposed amendments to its Articles of Association and the Rules of Procedure for the General Meeting of Shareholders, aimed at optimizing Board composition and reflecting the new appointments. These amendments require shareholders’ approval.

An Extraordinary General Meeting (EGM) is scheduled for 25 November 2025 at 10:00 a.m. in Shanghai, where shareholders will vote on these matters. Shareholders registered by 19 November 2025 are eligible to attend. The relevant proxy documents and additional details are available in the company’s circular dated 5 November 2025.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1188629197"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1188629197\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1188629197?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-06 06:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188629197","market":"hk","top_or_hot":-1,"title":"MicroPort MedBot (2252.HK) Proposes New Directors, Amends Governance Documents, and Convenes EGM","media":"Bulletin Express","content":"<p>Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK) has announced plans to appoint six new directors and amend its corporate governance documents. The new directors include four non-executive candidates—namely, Dr. Chang Zhaohua, Mr. Hiroshi Shirafuji, Mr. Norihiro Ashida, and Ms. Liang Min—as well as two independent non-executive candidates, Mr. Jonathan H. Chou and Dr. Guoen Liu. Upon approval, the Board will expand from eight to eleven members.</p>\n<p>The company has also proposed amendments to its Articles of Association and the Rules of Procedure for the General Meeting of Shareholders, aimed at optimizing Board composition and reflecting the new appointments. These amendments require shareholders’ approval.</p>\n<p>An Extraordinary General Meeting (EGM) is scheduled for 25 November 2025 at 10:00 a.m. in Shanghai, where shareholders will vote on these matters. Shareholders registered by 19 November 2025 are eligible to attend. The relevant proxy documents and additional details are available in the company’s circular dated 5 November 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MicroPort MedBot (2252.HK) Proposes New Directors, Amends Governance Documents, and Convenes EGM</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicroPort MedBot (2252.HK) Proposes New Directors, Amends Governance Documents, and Convenes EGM\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-06 06:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK) has announced plans to appoint six new directors and amend its corporate governance documents. The new directors include four non-executive candidates—namely, Dr. Chang Zhaohua, Mr. Hiroshi Shirafuji, Mr. Norihiro Ashida, and Ms. Liang Min—as well as two independent non-executive candidates, Mr. Jonathan H. Chou and Dr. Guoen Liu. Upon approval, the Board will expand from eight to eleven members.</p>\n<p>The company has also proposed amendments to its Articles of Association and the Rules of Procedure for the General Meeting of Shareholders, aimed at optimizing Board composition and reflecting the new appointments. These amendments require shareholders’ approval.</p>\n<p>An Extraordinary General Meeting (EGM) is scheduled for 25 November 2025 at 10:00 a.m. in Shanghai, where shareholders will vote on these matters. Shareholders registered by 19 November 2025 are eligible to attend. The relevant proxy documents and additional details are available in the company’s circular dated 5 November 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02252","symbol_name":"微创机器人-B","start_time":0,"source_url":"","article_id":"1188629197","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188629197","pubTimestamp":1762382667,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK) has announced plans to appoint six new directors and amend its corporate governance documents. The new directors include four non-executive...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02252":"微创机器人-B"},"translate_title":"微创医疗机器人(2252.HK)提名新董事、修订管治文件、召开临时股东大会","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02252":1},"content_text":"Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK) has announced plans to appoint six new directors and amend its corporate governance documents. The new directors include four non-executive candidates—namely, Dr. Chang Zhaohua, Mr. Hiroshi Shirafuji, Mr. Norihiro Ashida, and Ms. Liang Min—as well as two independent non-executive candidates, Mr. Jonathan H. Chou and Dr. Guoen Liu. Upon approval, the Board will expand from eight to eleven members.\nThe company has also proposed amendments to its Articles of Association and the Rules of Procedure for the General Meeting of Shareholders, aimed at optimizing Board composition and reflecting the new appointments. These amendments require shareholders’ approval.\nAn Extraordinary General Meeting (EGM) is scheduled for 25 November 2025 at 10:00 a.m. in Shanghai, where shareholders will vote on these matters. Shareholders registered by 19 November 2025 are eligible to attend. The relevant proxy documents and additional details are available in the company’s circular dated 5 November 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}